Cargando…
Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
BACKGROUND/AIMS: This study was performed to compare the mucosal findings after esophagogastroduodenoscopy in two groups before and after the use of alendronate only and following administration of the enteric-coated alendronate (5 mg) and calcitriol (0.5 µg) combined drug (Maxmarvil, Yuyu Co.). MET...
Autores principales: | Mok, Ji Oh, Jung, Chan Hee, Kim, Chul Hee, Ryu, Chang Beom, Kim, Yeo Joo, Kim, Sang Jin, Park, Hyeong Kyu, Suh, Kyo Il, Yoo, Myung Hi, Byun, Dong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846995/ https://www.ncbi.nlm.nih.gov/pubmed/24307845 http://dx.doi.org/10.3904/kjim.2013.28.6.694 |
Ejemplares similares
-
The Efficacy and Safety of a Combined Alendronate and Calcitriol Agent (Maxmarvil): A Postmarketing Surveillance Study in Korean Postmenopausal Women with Osteoporosis
por: Suh, Hee-Won, et al.
Publicado: (2012) -
Efficacy and Safety of Weekly Alendronate Plus Vitamin D(3) 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial
por: Kim, Kwang Joon, et al.
Publicado: (2014) -
Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats
por: Nakamura, Yoshinari, et al.
Publicado: (2008) -
Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010) -
Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis
por: Yoo, Jun-Il, et al.
Publicado: (2017)